Clinical Trial Update: G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating G-CSF for prevention of febrile neutropenia in gynecologic cancer patients undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Febrile Neutropenia
• Gynecologic Cancer

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Lei Li | Conditions: Gynecologic Cancer, Myelosuppression Adult | Phase 4 | Status: UNKNOWN